Key Insights

Highlights

Success Rate

96% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.6%

1 terminated out of 38 trials

Success Rate

96.0%

+9.5% vs benchmark

Late-Stage Pipeline

13%

5 trials in Phase 3/4

Results Transparency

8%

2 of 24 completed with results

Key Signals

2 with results96% success

Data Visualizations

Phase Distribution

33Total
Not Applicable (26)
P 1 (1)
P 2 (1)
P 3 (2)
P 4 (3)

Trial Status

Completed24
Recruiting6
Active Not Recruiting2
Unknown2
Not Yet Recruiting2
Enrolling By Invitation1

Trial Success Rate

96.0%

Benchmark: 86.5%

Based on 24 completed trials

Clinical Trials (38)

Showing 20 of 20 trials
NCT07537595Completed

Efficacy of Cosmetic Products in Preventing Pigmentation Induced by High Energy Visible Light (HEVL) [400-450nm]

NCT07501000Not ApplicableCompletedPrimary

Evaluation of the Safety and Tolerability of a Brightening Treatment Paired With a Skincare Regimen

NCT07468175Not ApplicableCompletedPrimary

A 16-week Clinical Study Investigating a Dark Spot Corrector Serum in Women With Moderate Discrete Hyperpigmentation

NCT07429786Not ApplicableNot Yet RecruitingPrimary

Evaluation of Efficacy and Tolerabilty of MelaB3 Serum in Combination of 35% Glycolic Acid Peeling Compared to 35% Glycolic Acid Peeling Alone in Various Hyperpigmentation Conditions

NCT07162623Not ApplicableActive Not RecruitingPrimary

Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Oziva Bioactive Gluta Fizzy Effervescent Tablets on Subjects With Facial Dark Spots Such as Pimple Marks, Sunspots, Age Spots and Uneven Skin Tone

NCT07324759Not ApplicableNot Yet Recruiting

Clinical Study to Assess Safety, Effectiveness and In-Use Tolerability of Saffron Extract Capsules for Improving Skin Health and Reducing Signs of Aging on Healthy Adult Male and Female Subjects.

NCT05493280Not ApplicableCompletedPrimary

Fractionated 1927nm Laser for Hyperpigmentation in Fitzpatrick Skin Phototypes V and VI

NCT07136766Phase 3Enrolling By InvitationPrimary

An 18-week Study to Evaluate a Test Product With a Marketed Prescription Product

NCT07067879Not ApplicableRecruitingPrimary

The Effectiveness of a Novel Lip Product Containing Caulerpa Lentillifera Extract for Reducing Lip Hyperpigmentation

NCT07067515Phase 1Active Not RecruitingPrimary

Effectiveness of Omega-3 Poly Unsaturated Fatty Acids on The Treatment of Gingival Hyperpigmentation

NCT07040345Not ApplicableCompletedPrimary

Annurca Apple Peel Oleolite for the Treatment of Skin Hyperpigmentation

NCT05362929Not ApplicableRecruiting

Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color

NCT05165524Not ApplicableCompletedPrimary

Brightening Cream and Lasers in Post-sclerotherapy Hyperpigmentation

NCT06080035Not ApplicableCompletedPrimary

The Effects of Cetyl Tranexamate Mesylate on the Appearance of Acne-Related Hyperpigmentation

NCT06213987Phase 3Completed

The Efficacy Tretinoin Cream in the Treatment of Axillary Hyperpigmentation Associated With Acanthosis Nigricans

NCT06253468Not ApplicableRecruitingPrimary

Efficacy and Tolerability of Tested Formula After 3 Months of Treatment of Facial Hyperpigmentation of 3 Origins

NCT06268496Not ApplicableRecruitingPrimary

Efficacy and Tolerability of the Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins

NCT06253455Not ApplicableCompletedPrimary

Efficacy and Tolerability of the Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins

NCT06349447Not ApplicableRecruitingPrimary

Pilot Study of LED for PIE and PIH

NCT06320314Not ApplicableRecruitingPrimary

Efficacy and Tolerability of Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins

Scroll to load more

Research Network

Activity Timeline